Friday, March 19, 2010 Last update: 5:30 PM

State-by-State AND City-by-City FreshNews.com Delivers Company Tech News

AVANIR Pharmaceuticals, Inc.

print this company - email to a friend - join our eNewsletter

News articles for AVANIR Pharmaceuticals, Inc.:

Tuesday, February 2, 2010

AVANIR to Present at the 12th Annual BIO CEO & Investor Conference

Posted at 02/02/2010 - 4:15pm
AVANIR Pharmaceuticals Announces Fiscal 2010 First Quarter Financial Results

Posted at 02/02/2010 - 8:30am

Tuesday, January 26, 2010

AVANIR Pharmaceuticals Invites Investors to Fiscal 2010 First Quarter Conference Call

Posted at 01/26/2010 - 8:30am

Wednesday, December 9, 2009

AVANIR Pharmaceuticals Presents Zenvia Phase III Results in Amyotrophic Lateral Sclerosis Patient Cohort at the International Symposium on ALS / MND

Posted at 12/09/2009 - 8:30am

Wednesday, November 25, 2009

AVANIR to Present at the Piper Jaffray Health Care Conference

Posted at 11/25/2009 - 8:30am

Tuesday, November 24, 2009

AVANIR Pharmaceuticals Announces Fiscal 2009 Fourth Quarter and Full Year Financial Results

Posted at 11/24/2009 - 8:30am

Wednesday, November 11, 2009

AVANIR to Present at the Lazard Healthcare Conference

Posted at 11/11/2009 - 7:30am

Tuesday, October 20, 2009

AVANIR to Present at the BIOCOM Investor Conference

Posted at 10/20/2009 - 5:30am

Tuesday, October 13, 2009

AVANIR Pharmaceuticals Presents Detailed Zenvia Confirmatory Phase III Results in Late-Breaker Session at American Neurological Association Meeting

Posted at 10/13/2009 - 10:00am

Friday, October 9, 2009

AVANIR Pharmaceuticals Presents Zenvia Phase III Results in Multiple Sclerosis Patient Population at Controversies in Neurology Congress

Posted at 10/09/2009 - 5:30am

Wednesday, October 7, 2009

AVANIR Pharmaceuticals Announces Receipt of Notice of Allowance of New U.S. Patent on Zenvia

Posted at 10/07/2009 - 5:30am

Tuesday, October 6, 2009

AVANIR to Present Pivotal Zenvia Phase III Data at American Neurological Association and World Congress on Controversies in Neurology Annual Meetings

Posted at 10/06/2009 - 5:30am

Wednesday, September 9, 2009

AVANIR to Present at the NewsMakers in the Biotech Industry Conference

Posted at 09/09/2009 - 5:30am

Wednesday, September 2, 2009

AVANIR to Present at the Thomas Weisel Partners and the Rodman & Renshaw Healthcare Conferences

Posted at 09/02/2009 - 5:30am

Thursday, August 27, 2009

AVANIR Raises $10.6 Million Through the Sale of Common Stock

Posted at 08/27/2009 - 5:30am

Tuesday, August 11, 2009

AVANIR Announces Positive Phase III Study Results for Zenvia

Posted at 08/11/2009 - 4:00am

Monday, August 10, 2009

AVANIR Pharmaceuticals Schedules Conference Call to Discuss Phase III Results for Zenvia™ in Pseudobulbar Affect

Posted at 08/10/2009 - 1:22pm

Monday, June 29, 2009

AVANIR Pharmaceuticals Announces It Has Been Added to the Russell 3000® Index

Posted at 06/29/2009 - 10:00am

Wednesday, June 3, 2009

AVANIR Regains Compliance with NASDAQ Listing Requirements

Posted at 06/03/2009 - 5:30am

Tuesday, May 12, 2009

AVANIR to Present at the Deutsche Bank 34th Annual Health Care Conference

Posted at 05/12/2009 - 5:30am

Add new comment

Biotech/Biomedical/Health

Science/ Research

Trade Shows

Financials/Webcasts

California

United States